GE HealthCare Stock Outlook: Is Wall Street Bullish or Bearish?
Wall Street analysts are generally bullish on GE HealthCare (GEHC), with 11 'Strong Buy' ratings. Argus raised its price target to $110, maintaining a 'Buy' rating. The mean target is $87.87, a 6.8% premium over the current price, and the highest target suggests 33.6% upside.
How this was made

The 30-second read
Why it matters
The upgrade could attract buying interest and support the stock price in the short term.
Market read
Analyst target raise is a fresh catalyst for a large‑cap health‑care stock, offering a potential trade idea.
What to watch
Potential regulatory or reimbursement risks are not addressed in the target raise.
Background
The article reports a fresh analyst rating and price‑target update for GE HealthCare.
Ticker impact
Argus raised its price target on GE HealthCare to $110 and kept a Buy rating.
likely upward pressure as investors price in the new $110 target.
The target represents a 33.6% upside from current levels, indicating a material catalyst for the stock.
Market effects
Higher target may lift sentiment in the health‑care equipment sector.
U.S. market focus on large‑cap health‑care stocks could see modest gains.
Limited to investors tracking U.S. health‑care equities.
Counterpoint
Some investors may view the target as overly optimistic given competitive pressures.
Key entities
- analystArgus
Equity research firm that raised the price target.
- companyGE HealthCare
U.S. listed health‑care equipment and services provider.

